GIM
KRRO icon

Granahan Investment Management’s Korro Bio KRRO Stock Holding History

Granahan Investment Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-787
Closed -$202K – 185
2021
Q4 		$202K Sell
787
-74
-9% -$22.5K ﹤0.01% 186
2021
Q3 		$304K Sell
861
-1,689
-66% -$665K 0.01% 192
2021
Q2 		$1.27M Buy
2,550
+504
+25% +$246K 0.02% 186
2021
Q1 		$972K Sell
2,046
-395
-16% -$767K 0.02% 183
2020
Q4 		$4.3M Buy
2,441
+86
+4% +$114K 0.1% 140
2020
Q3 		$2.26M Buy
2,355
+176
+8% +$189K 0.08% 146
2020
Q2 		$2.53M Sell
2,179
-45
-2% -$40.7K 0.09% 142
2020
Q1 		$1.98M Sell
2,224
-1,156
-34% -$1.25M 0.11% 133
2019
Q4 		$2.96M Buy
+3,380
New +$2.63M 0.14% 122

Other funds holding KRRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Granahan Investment Management's KRRO Position: Q1 2022 in Review

Granahan Investment Management sold out of Korro Bio (KRRO) in Q1 2022, closing a stake of 787 shares — an estimated $202K sold.

Granahan Investment Management first reported a position in KRRO in Q4 2019 and held it in 9 quarters. The position peaked at $4.3M in Q4 2020. 85 funds tracked by Wall St. Rank hold KRRO as of Q1 2022.

  • Granahan Investment Management reported no remaining Korro Bio position as of Q1 2022 after selling out during the quarter.
  • Granahan Investment Management sold 787 Korro Bio shares in Q1 2022, an estimated $202K.
  • Granahan Investment Management first reported a position in Korro Bio in Q4 2019 and held it in 9 quarters.
  • Granahan Investment Management's Korro Bio position peaked at $4.3M in Q4 2020.
  • 85 funds tracked by Wall St. Rank held Korro Bio as of Q1 2022.

Based on Granahan Investment Management's 13F filing for Q1 2022, filed 16 May 2022.